Sponsor hub
New York State Psychiatric Institute clinical trial failures
Review 56 stopped clinical trials from New York State Psychiatric Institute, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 1 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 35
- OTHER/UNKNOWN
- 19
- EFFICACY/FUTILITY
- 1
- REGULATORY
- 1
Notable sponsors
- New York State Psychiatric Institute
- 56
Related phases
- Phase II
- 17
- Phase IV
- 16
- Phase I
- 12
- Unknown
- 5
- Phase III
- 4
Crawlable stopped-trial records
Open ExploreShowing up to 56 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase IV Depression, Unipolar trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
The U.S. Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP) issued an FWA restriction on NYSPI research that also included a pause of human subjects research as of June 23, 2023.
Phase I Schizophrenia trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. NKI site is open for enrollment.
Phase IV Bipolar Depression trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Funding decision
Phase II Cannabis trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.
Phase I Healthy trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.
Phase II Cannabis trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.
Phase I Healthy trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
NIMH institute wide suspension
Phase II Obsessive-Compulsive Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
The NYSPI site is currently paused and has been paused since an institutional pause on human subjects research on March 14, 2024.
Phase II Cannabis Use trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.
Phase III Major Depressive Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
NYSPI paused human subjects research (HSR) 6/23. The US Dept. of Health and Human Services Office of Human Research Protections issued an FWA restriction pausing such research 6/23/23. The IO and IRB paused HSR 6/12/23. Hence no current enrolling.
Phase II Opioid Overdose trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
The U.S. Department of Health and Human Services Office of Human Research Protections issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. Recruitment for this trial will not reopen.
Phase II Alcohol Use Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.
Phase III Cocaine Use Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Funding
Phase I Obsessive-Compulsive Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
The Principal Investigator is no longer at the Institution and a request for early termination of the grant supporting the study was submitted to NIH.
Phase III Suicidal Ideation trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will not resume recruitment after the resumption of research.
Early Phase I Knee Replacement trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Funding not obtained
Phase IV Social Anxiety Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
COVID-19 restrictions
Phase IV Major Depressive Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
The project end date was reached prior to the full sample enrollment
Phase IV Depression trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Study terminated by sponsor (NIMH)
Phase IV Obsessive-compulsive Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
Study has been withdrawn due to reconsideration of study design.
Unknown Attention Deficit Hyperactivity Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Recruitment/enrollment ended early due to the COVID-19 pandemic
Phase IV Depressive Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Study terminated by sponsor (NIMH)
Phase II Chemotherapy-induced Peripheral Neuropathy trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Funding being sought
Phase III Heroin Dependence trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
continuing study was no longer feasible
Phase IV Bipolar Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
Reassessment of rationale for study
Phase I Cannabis trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Recruitment difficulties
Phase II Cannabis Use trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
During a piloting phase with our staff, the technology/eye-tracking device did not collect outcomes as expected.
Phase IV Post Traumatic Stress Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Unable to recruit participants in a timely fashion due to COVID pandemic
Phase I Clinical High Risk for Psychosis trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Combination of insufficient funding and lack of compelling findings
Phase II Opioid-use Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
no funding available to continue
Phase II Schizophrenia trial by New York State Psychiatric Institute. Stop reason: REGULATORY.
ITI-007 approved by FDA
Phase I Chronic Pain trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
funding
Phase I Lung Cancer trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
funding
Unknown Generalized Anxiety Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Insufficient funding
Phase IV Depression trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
recruitment of this population was not feasible
Phase IV Opioid-use Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
PI leaving the institute
Phase II Opioid-use Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Study terminated by sponsor due to bad risk/benefit ratio.
Early Phase I Cannabis Use Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
terminated due to lorcaserin recall
Phase II Cigarette Smoking trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Ran out of funding
Phase I Opioid Use Disorder trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
The study was discontinued by the sponsor. No results to report
Phase II Attention Deficit Hyperactivity Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Recruitment Rate too slow
Unknown Post Treatment Lyme Syndrome (PTLS) trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Slow recruitment due to strict inclusion/exclusion criteria
Phase I Glioblastoma trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
Lack of subject interest due to study design
Phase I Cocaine Dependence trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
An analysis demonstrated that running the final participants was unnecessary.
Phase II Benzodiazepine Dependence trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Insufficient recruitment, funding terminated from sponsor
Phase IV Major Depressive Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
No participants enrolled.
Phase IV Depressive Illness trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
PI Retired and no data was collected
Phase IV Depression trial by New York State Psychiatric Institute. Stop reason: EFFICACY/FUTILITY.
Interim analysis showed differential treatment effects.
Phase II Alcoholism trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Inability to recruit patients.
Phase IV Obesity trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Terminated due to sibutramine being withdrawn from the market.
Phase IV Cocaine-Related Disorders trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.
Study never opened; never enrolled participants
Phase I Heroin Dependence trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
The funding period ended.
Phase II Obsessive-Compulsive Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
poor tolerability and low enrollment rate
Unknown Schizophrenia trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Enrollment was slower than anticipated by the investigators and the funding research foundation.
Phase II Cocaine Dependence trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
Funding ran out
Unknown Tobacco Use Disorder trial by New York State Psychiatric Institute. Stop reason: OPERATIONAL.
No participants enrolled. Changed requirements for studying e-cigarettes.